Consumer Staples · Perfumes, Cosmetics & Other Toilet Preparations

SLSN SOLESENCE, INC. SEC Filings & Insider Trading Activity 2026

company
CIK 883107101 filings
Russell 2000

SLSN at a glance

SOLESENCE, INC. (SLSN, SEC CIK 883107) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 12, 2026, an 8-K current report on November 12, 2026 and Form 4 insider filings as recently as December 30, 2025. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), SOLESENCE, INC. (SLSN) reported revenue of $62.1 million (up 18.6% from FY2024) and net income of $1.8 million. Diluted EPS was $0.02.
  • As of September 30, 2026, 10 institutional investment managers tracked by SignalX reported holding SOLESENCE, INC. (SLSN) shares worth $1.6 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by WHITMORE R JANET on December 24, 2025 of 1,500 shares at $1.91 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$62.1M
+18.6% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
10 funds
$1.6M · −4 vs prior quarter
Latest 8-K
Nov 12, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Quarterly revenue $20,163, up $5,566 YoY from $14,597, driven by stronger brand-partner demand
  • Product revenue $19,978 versus $14,533 YoY, while nine-month product revenue declined 2.4%
  • Cost of revenue $12,235 versus $11,123 YoY, with no quarterly margin percentage disclosed
  • Operating cash flow $8,427 for nine months versus $(10,386) YoY, while cash totaled $1,270
  • 2026 capital spending outlook $0.5 million to $1.5 million, with supplier-price and wage inflation potential headwinds

AI summary of the SLSN 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 12, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q3 revenue $20.2M, up 38% year over year, reversing nine-month revenue decline to $48.5M versus $49.6M
  • Gross margin expanded to 39.3% from 23.8%, signaling meaningful manufacturing efficiency and product-mix improvement

Item 2.02: Results of Operations and Financial Condition

  • Exhibit 99.1 contains SOLESENCE’s fiscal-year 2026 results announcement
  • Investor-relevant earnings figures and management commentary are in the attached press release
Filed Oct 5, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • Maturity dates extended from April 30, 2027 to May 31, 2028 across term, A/R, and revolving loans
  • Amendments provide roughly 13 additional months before loan maturities
Filed Oct 2, 2026Full analysis →

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule

  • Nasdaq deficiency: closing bid below $1.00 for 30 consecutive trading days
  • No immediate delisting, continued Nasdaq Capital Market listing and SEC reporting

AI summaries of SLSN 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for SLSN

Don't miss the next SLSN filing

  • Alerts as it files. A push when SLSN files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut SLSN, by share count.
  • Ask anything. An AI agent that reads every SLSN filing and answers with sources.

SLSN alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
WHITMORE R JANETBuyDec 24, 2025$1.91
WHITMORE R JANETBuyDec 24, 2025$1.92
WHITMORE R JANETBuyNov 19, 2025$1.95
WHITMORE R JANETBuyNov 19, 2025$1.89
WHITMORE R JANETBuyNov 18, 2025$1.83
WHITMORE R JANETBuyNov 17, 2025$1.87
WHITMORE R JANETBuyNov 14, 2025$1.73

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$52.3M$62.1M
Gross Profit-$16.2M$16.1M
Operating Income-$5.1M$1.6M
Net Income-$4.2M$1.8M
Gross Margin-30.9%25.9%
Op. Margin-9.8%2.5%
Net Margin-8.1%2.9%
Balance Sheet
Total Assets$32.9M$50.0M$50.1M
Equity$1.9M$14.9M$17.6M
ROE-28.3%10.2%
Per Share
EPS-$0.07$0.02
Cash Flow
Operating CF-$2.0M-$8.6M
CapEx$1.1M$4.6M-

Source: XBRL data in SOLESENCE, INC. (SLSN)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate SLSN share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
SLSN shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202610$1.6M
Q2 202614$1.7M
Q1 202614$2.7M
Q4 202514$4.6M
Q3 202511$8.1M
Q2 202510$10.2M
Position changes: Q2 2026 → Q3 2026
Top Buyers
None this quarter.
Top Sellers
New Positions
None this quarter.

Source: 13F-HR filings on SEC EDGAR (aggregated from 73 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

SLSN filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 12, 2026Analysis
8-KNov 12, 2026Analysis-
8-KOct 5, 2026Analysis-
8-KOct 2, 2026Analysis-
8-KAug 21, 2026Analysis-
8-KAug 20, 2026Analysis-
10-QAug 19, 2026Analysis
8-KJul 10, 2026Analysis-
8-KMay 12, 2026Analysis
10-QMay 12, 2026Analysis
8-KApr 29, 2026Analysis-
8-KMar 31, 2026--
10-KMar 31, 2026-
4Dec 30, 2025-
4Dec 11, 2025-
8-KDec 3, 2025-
8-KDec 1, 2025-
10-QNov 12, 2025-
10-QAug 14, 2025-
10-QMay 13, 2025-
10-KMar 31, 2025Analysis
10-QNov 12, 2024-
10-QAug 9, 2024-
10-QMay 13, 2024-
10-KMar 28, 2024-

Related Consumer Staples companies

All Consumer Staples →

SLSN SEC filings: frequently asked questions

Which institutions hold SLSN stock?

As of September 30, 2026, the largest SOLESENCE, INC. (SLSN) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($667,000), BlackRock ($268,000), BNY Mellon ($260,000), Millennium Management ($215,000), Morgan Stanley ($153,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was SLSN's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), SOLESENCE, INC. (SLSN) reported revenue of $62.1 million (up 18.6% from FY2024) and net income of $1.8 million. Diluted EPS was $0.02. The figures come from the XBRL data in the 10-K.

What did SLSN report in its latest 8-K?

SOLESENCE, INC. (SLSN) filed an 8-K on November 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 revenue $20.2M, up 38% year over year, reversing nine-month revenue decline to $48.5M versus $49.6M.

What are the latest SLSN SEC filings?

SOLESENCE, INC. (SLSN) filed its latest 10-K annual report on March 31, 2026, a 10-Q quarterly report on November 12, 2026, an 8-K current report on November 12, 2026 and a Form 4 insider filing on December 30, 2025.

What is SLSN's SEC CIK number?

SOLESENCE, INC. (SLSN)'s SEC Central Index Key (CIK) is 883107. EDGAR lists every SLSN filing under that number.

Ask anything about SLSN

The research agent reads SLSN's filings, financials, insider trades and 13F holders, then answers with sources.